◼ Archived
Business
🔮 fades ✓
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
Eli Lilly's acquisition of Merida Biosciences for up to $2.875 billion is making waves in the biotech industry.
Autoimmune Disease
7 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Autoimmune Disease
This hub groups 7 separate news trends connected to Autoimmune Disease, spanning June 23, 2026 through August 31, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 51 article observations and 51 source signals, led by Business, Health, Science coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Health
🔮 fades ✓
Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial
A cancer therapy has shown promise in treating severe rheumatoid arthritis, offering new hope to patients.
◼ Archived
Business
🔮 fades ✓
Deerfield-backed Boulevard Bio embarks on ‘beautiful path to a cure’ with trio of immunology drugs
Boulevard Bio debuts with $65 million in funding to advance a pipeline of targeted antibody therapies focused on autoimmune disease.
◼ Archived
Science
🔮 fades ✓
3D DNA mapping in rare immune cells reveals new genes linked with autoimmune disease risk
Scientists have identified 100 genes linked to Crohn’s disease risk by mapping 3D DNA in rare immune cells
◼ Archived
Business
🔮 fades ✗
Biohacker Bryan Johnson reveals he has been diagnosed with an incurable stomach disease
Biohacker Bryan Johnson has disclosed a diagnosis of an incurable autoimmune stomach disease.
◼ Archived
Health
🔮 fades ✗
Bryan Johnson is battling THIS rare autoimmune disease: Biohacker shares his health issue in recent post
Longevity expert Bryan Johnson has disclosed a diagnosis of autoimmune gastritis, a rare condition causing significant internal damage.
◼ Archived
Health
🔮 fades ✓
Two patients with severe autoimmune disease remain relapse-free for over 15 years after stem cell transplant
Two patients with severe autoimmune disease have remained relapse-free for over 15 years following stem cell transplants.